Macular degeneration treatment. Close-up of the eyes of 75-year-old female patient receiving an intra-ocular bevacizumab (Avastin) injection to treat
Macular degeneration treatment. Close-up of the eyes of 75-year-old female patient receiving an intra-ocular bevacizumab (Avastin) injection to treat macular degeneration and retinal vein thrombosis. Bevacizumab is an angiogenesis inhibitor, a drug that slows the growth of new blood vessels. It is usually used in chemotherapy to treat a number of cancers but here is being used to treat age-related eye conditions. Macular degeneration caused damage to the macula, the central area of the retina in the eye, which leads to a loss of vision in the central field of vision. Retinal vein thrombosis, or central retinal vein occlusion, is a blockage of the central retinal vein. As one of only two sources of blood supply to the eye, occlusion of the central retinal vein can lead to blindness.
Size: 5380px × 3591px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: 75, 75-year-, 75-years-, abnormal, adult, age-related, angiogenesis, avastin, bevacizumab, blockage, blocked, caucasian, central, clinical, close-, condition, degeneration, detail, disease, diseased, disorder, drug, drugs, elderly, eye, eyeball, eyes, face, female, healthcare, hospital, human, inhibitor, injection, intra-ocular, intraocular, macula, macular, medical, medicine, occluded, occlusion, ocular, older, ophthalmic, ophthalmological, ophthalmology, patient, people, person, retina, retinal, seventies, sight, thrombosis, treating, treatment, unhealthy, vein, vision, white, woman
